Based on the earnings call transcript, I anticipate a neutral to slightly positive short-term impact on 3M's stock price over the next 1-2 weeks. While the company lowered full-year EPS guidance due to currency headwinds and macro uncertainties, there were several positive factors: solid Q1 results with 2% organic growth despite challenging conditions, strong margins ex-acquisitions at 22%, continued growth in key markets like healthcare and consumer, and aggressive capital return to shareholders. Management maintained their organic growth outlook of 2-5% for the year and expressed confidence in second half improvement. The balanced mix of headwinds and strengths suggests limited near-term stock volatility.

[0]